The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2019

Filed:

Dec. 20, 2013
Applicant:

Jiuzhitang Co., Ltd., Changsha, Hunan, CN;

Inventors:

Jinhua Zhao, Yunnan, CN;

Mingyi Wu, Yunnan, CN;

Na Gao, Yunnan, CN;

Zi Li, Yunnan, CN;

Sensen Lai, Yunnan, CN;

Longyan Zhao, Yunnan, CN;

Assignee:

Jiuzhitang Co., Ltd., Changsha, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C08B 37/00 (2006.01); C07H 5/06 (2006.01); A61K 31/726 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
C08B 37/0063 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 31/726 (2013.01); C07H 5/06 (2013.01);
Abstract

A low-molecular-weight fucosylated glycosaminoglycan (aTFG) containing 2,5-anhydrated talose, alditol, glycosylamine or N-substituted glycosylamine monosaccharide composition thereof, preparation method thereof, pharmaceutical compositions containing the aTFG, and use thereof for preventing and/or treating thrombotic diseases are provided. The aTFG has potent anticoagulant activity targeting at intrinsic coagulation factor Xase, and inhibiting thrombogenesis, and therefore can be used as drugs for preventing and/or treating cardiovascular and cerebrovascular diseases.


Find Patent Forward Citations

Loading…